Overview Efficacy and Safety of Roflumilast Cream in Subjects With Atopic Dermatitis Status: COMPLETED Trial end date: 2025-07-13 Target enrollment: Participant gender: Summary This study will assess the safety and efficacy of Roflumilast cream versus vehicle applied once a day for 4 weeks by subjects with atopic dermatitis.Phase: PHASE3 Details Lead Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.